Born2Grow Venture Partners has invested €3m in a series-B funding round for Implandata Ophthalmic Products, with participation from existing backers.
Exit represents an 18x return on Octopus's initial investment and a 9x return on its total investment
Deal follows M&A litigation initiated after coronavirus uncertainty and financing difficulties
Rehms Building Technology has sold the businesses as part of its self-administration proceedings
Startup has so far raised more than €100m and is backed by VC firms Seed Capital, Greyhound, Augustinus, Socii and private investor David Helgason